Evolus, Inc. ( EOLS) - Key Metrics
EOLS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.40 | $0 | $0.20 | $0.18 |
| 2025Q3 | $1.07 | -$0.24 | -$0.23 | -$0.26 |
| 2025Q2 | $1.08 | -$0.27 | -$0.38 | -$0.39 |
| 2025Q1 | $1.08 | -$0.30 | -$0.25 | -$0.27 |
EOLS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 824.46 |
| 2025Q3 | ? | -6.31 |
| 2025Q2 | ? | -8.67 |
| 2025Q1 | ? | -10.14 |
EOLS
Price: $6.58
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 16622
Market Capitalization: 418.8 million